DSpace at RU >

Search Results

Results 1-11 of 11.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2011	Prednisolone-induced changes in gene-expression profiles in healthy volunteers.	Toonen, E.J.M.; Fleuren, W.W.M.; Nassander, U.; Lierop, M.J.C. van; Bauerschmidt, S.; Dokter, W.H.; Alkema, W.
	2011	Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cells.	Linssen, M.M.; Raalte, D.H. van; Toonen, E.J.M.; Alkema, W.; Zon, G.C. van der; Dokter, W.H.; Diamant, M.; Guigas, B.; Ouwens, D.M.
	2010	Anti-TNF pharmacogenomics in rheumatoid arthritis: towards personalized therapeutics.	Toonen, E.J.M.
	2010	Multiplex screening of 22 single-nucleotide polymorphisms in 7 Toll-like receptors: an association study in rheumatoid arthritis.	Enevold, C.; Radstake, T.R.D.J.; Coenen, M.J.H.; Fransen, J.; Toonen, E.J.M.; Bendtzen, K.; Riel, P.L.C.M. van
	2010	Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor	Frijters, R.J.J.M.; Fleuren, W.W.M.; Toonen, E.J.M.; Tuckermann, J.P.; Reichardt, H.M.; Maaden, H. van der; Elsas, A. van; Lierop, M.J.C. van; Dokter, W.; Vlieg, J. de; Alkema, W.
	2010	Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome	Coenen, M.J.H.; Enevold, C.; Barrera, P.; Schijvenaars, M.M.V.A.P.; Toonen, E.J.M.; Scheffer, H.; Padyukov, L.; Kastbom, A.; Klareskog, L.; Barton, A.; Kievit, W.; Rood, M.J.; Jansen, T.L.Th.A.; Swinkels, D.W.; Riel, P.L.C.M. van; Franke, B.; Bendtzen, K.; Radstake, T.R.D.J.
	2010	Tumour necrosis factor alpha -308G->A polymorphism is not associated with response to TNFalpha blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis.	Pavy, S.; Toonen, E.J.M.; Miceli-Richard, C.; Barrera, P.; Riel, P.L.C.M. van; Criswell, L.A.; Mariette, X.; Coenen, M.J.H.
	2008	Functional variants of the macrophage migration inhibitory factor do not infer risk of cardiovascular disease in rheumatoid arthritis.	Radstake, T.R.D.J.; Fransen, J.; Riel, P.L.C.M. van; Toonen, E.; Coenen, M.; Donn, R.
	2008	The functional variant (Asp299gly) of toll-like receptor 4 (TLR4) influences TLR4-mediated cytokine production in rheumatoid arthritis.	Roelofs, M.F.; Wenink, M.H.; Toonen, E.J.M.; Coenen, M.J.J.; Joosten, L.A.B.; Berg, W.B. van den; Riel, P.L.C.M. van; Radstake, T.R.D.J.
	2007	Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis.	Coenen, M.J.J.; Toonen, E.J.M.; Scheffer, H.; Radstake, T.R.D.J.; Barrera, P.; Franke, B.
	2007	Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis.	Radstake, T.R.D.J.; Fransen, J.; Toonen, E.J.M.; Coenen, M.J.H.; Eijsbouts, A.E.; Donn, R.; Hoogen, F.H.J. van den; Riel, P.L.C.M. van

1